Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05592899 · ClinicalTrials.gov registry record

Head and Neck Trauma Registry, Protocol ID: 032.MBSI.2021.D

A clinical trial of Craniocerebral Trauma, sponsored by Methodist Health System.

Recruiting
Registry status
30
Enrollment target
1
Study location

NCT05592899: Recruiting study of Craniocerebral Trauma, sponsored by Methodist Health System.

NCT05592899 is a study of Craniocerebral Trauma that is actively recruiting participants, run by Methodist Health System. The registered enrollment target is 30 participants, below the 210-participant average among 6 other Craniocerebral Trauma trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05592899, a study of Craniocerebral Trauma, is actively recruiting participants, sponsored by Methodist Health System.

RECRUITING
Registry status
30 participants
Enrollment target
1
Study location

Study Summary

This is a retrospective registry dataset of all adults who presented with cervical and/or skull base fractures or a subdural hematoma at Methodist Dallas Medical Center (MDMC) and had consults to the neurological surgery department beginning in January of 2016, and continuing until a statistically significant number of cases are obtained.

Conditions Studied

Study Locations (1)

Texas

  • Methodist Moody Brain and Spine Institute, Methodist Dallas Medical Center - Dallas

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2021-08-23
Est. Completion 2024-08-23
Methodist Health System

125 total trials

What NCT05592899 shows while recruiting

NCT05592899 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 210-participant average among 6 other Craniocerebral Trauma trials with a reported enrollment target (86% lower).

The record links to 1 condition, with Craniocerebral Trauma appearing as the primary indexed condition, and to 0 interventions.

NCT05592899 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT05592899 about?

NCT05592899 is a clinical study titled "Head and Neck Trauma Registry, Protocol ID: 032.MBSI.2021.D". This is a retrospective registry dataset of all adults who presented with cervical and/or skull base fractures or a subdural hematoma at Methodist Dallas Medical Center (MDMC) and had consults to the neurological surgery department beginning in January of 2016, and continuing until a statistically s...

What is the current status of trial NCT05592899?

This trial is currently recruiting. The enrollment target is 30 participants. The study started on 2021-08-23. Estimated completion is 2024-08-23.

What conditions does trial NCT05592899 study?

This clinical trial studies the following conditions: Craniocerebral Trauma.

Who is sponsoring clinical trial NCT05592899?

This trial is sponsored by Methodist Health System, which has 125 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05592899 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Craniocerebral Trauma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05592899, the US trial registry maintained by the National Library of Medicine. NCT05592899 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.